Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Zumel Marne, María Ángela, 1984-
  • dc.contributor.author Castaño Vinyals, Gemma
  • dc.contributor.author Cardis, Elisabeth
  • dc.date.accessioned 2020-06-10T07:07:43Z
  • dc.date.available 2020-06-10T07:07:43Z
  • dc.date.issued 2020
  • dc.description.abstract Introduction: We used data from MOBI-Kids, a 14-country international collaborative case-control study of brain tumors (BTs), to study clinical characteristics of the tumors in older children (10 years or older), adolescents and young adults (up to the age of 24). Methods: Information from clinical records was obtained for 899 BT cases, including signs and symptoms, symptom onset, diagnosis date, tumor type and location. Results: Overall, 64% of all tumors were low-grade, 76% were neuroepithelial tumors and 62% gliomas. There were more males than females among neuroepithelial and embryonal tumor cases, but more females with meningeal tumors. The most frequent locations were cerebellum (22%) and frontal (16%) lobe. The most frequent symptom was headaches (60%), overall, as well as for gliomas, embryonal and 'non-neuroepithelial' tumors; it was convulsions/seizures for neuroepithelial tumors other than glioma, and visual signs and symptoms for meningiomas. A cluster analysis showed that headaches and nausea/vomiting was the only combination of symptoms that exceeded a cutoff of 50%, with a joint occurrence of 67%. Overall, the median time from first symptom to diagnosis was 1.42 months (IQR 0.53-4.80); it exceeded 1 year in 12% of cases, though no particular symptom was associated with exceptionally long or short delays.Conclusions: This is the largest clinical epidemiology study of BT in young people conducted so far. Many signs and symptoms were identified, dominated by headaches and nausea/vomiting. Diagnosis was generally rapid but in 12% diagnostic delay exceeded 1 year with none of the symptoms been associated with a distinctly long time until diagnosis.
  • dc.description.sponsorship This work was supported by the MOBI-Kids study and the work in this study was obtained from the European Community's Seventh Framework Programme under Grant Agreements Number 226873—the MOBI-Kids Project—and 603794—the GERoNiMO project. Additional funds for the coordination of MOBI-Kids were obtained from the Spanish Ministry of Science and Innovation (MINECO), while complementary funds for the conduct of MOBI-Kids in Spain were obtained from the Spanish Health Research Fund (FIS) of the National Institute for Health Carlos III. Italian participation is partially supported by a Ministry of Health grant (RF-2009-1546284). In Canada, funding was provided by a grant from the Canadian Institutes for Health Research under a peer-reviewed university-industry partnership program that involved the Canadian Wireless Telecommunications Association, who provided technical data on wireless telecommunications practices in Canada. The German study centre received additional support by the Federal Office for Radiation Protection (BfS). Japanese participation in MOBI-Kids was supported by the Ministry of Internal Affairs and Communications. New Zealand participation was supported by Health Research Council and Cure Kids. In France, this study received funds from the French National Agency for Sanitary Safety of Food, Environment and Labour (ANSES, contract FSRF2008-3), French National Cancer Institute (INCa), Pfizer Foundation and League against cancer. India received funding from Board of Research in Nuclear Sciences (BRNS). The funding sources had no role in: the study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the article for publication.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Zumel-Marne A, Kundi M, Castaño-Vinyals G, Alguacil J, Petridou ET, Georgakis MK, et al. Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study. J Neurooncol. 2020 Apr; 147(2):427-40. DOI: 10.1007/s11060-020-03437-4
  • dc.identifier.doi http://dx.doi.org/10.1007/s11060-020-03437-4
  • dc.identifier.issn 0167-594X
  • dc.identifier.uri http://hdl.handle.net/10230/44943
  • dc.language.iso eng
  • dc.publisher SpringerOpen
  • dc.relation.ispartof Journal of Neuro-Oncology. 2020 Apr; 147(2):427-40
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/226873
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/603794
  • dc.rights Copyright © The Author(s) 2020. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by/4.0/
  • dc.subject.keyword Brain tumor
  • dc.subject.keyword Central nervous system tumor
  • dc.subject.keyword Clinical characteristic
  • dc.subject.keyword Diagnosis
  • dc.subject.keyword Symptom
  • dc.title Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion